NCT04736979View on ClinicalTrials.gov

Antibiotic PRophylAxis Based on infeCTIve Risk in Cardiac Implantable Electronic Device

CompletedOBSERVATIONAL
Enrollment

1,044

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Device Related Infection
Interventions
DRUG

amoxicillin clavulanate

dosage according to Shariff score and creatinine clearance

All Listed Sponsors
lead

University Hospital of Ferrara

OTHER

NCT04736979 - Antibiotic PRophylAxis Based on infeCTIve Risk in Cardiac Implantable Electronic Device | Biotech Hunter | Biotech Hunter